Fresenius Medical Care AG Capital Expenditures (CapEx) Growth & History (FME)

Fresenius Medical Care AG's capital expenditures (capex) was €915.4M for fiscal 2025.

View full Fresenius Medical Care AG company overview

Fresenius Medical Care AG annual capital expenditures (capex) history

Fresenius Medical Care AG annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31€915.4M€216.0M+30.89%
20242024-12-31€699.4M€14.8M+2.16%
20232023-12-31€684.6M−€39.4M−5.44%
20222022-12-31€724.0M
20192019-12-31€1.12B€67.5M+6.39%
20182018-12-31€1.06B€112.8M+11.95%
20172017-12-31€944.5M€13.9M+1.50%
20162016-12-31€930.5M€71.6M+8.34%
20152015-12-31€858.9M

Fresenius Medical Care AG capital expenditures (capex) trends

Between the periods ended 2015-12-31 and 2025-12-31, Fresenius Medical Care AG's capital expenditures (capex) increased from €858.9M to €915.4M, a change of €56.5M. The latest reported quarter, Q2 2026, shows €240.4M.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Fresenius Medical Care AG source filings ↗

Community posts

It’s quiet here.

No posts about FME yet. Start the conversation.

Write the first post